Welcome to our dedicated page for ETRACS Whitney US Critical Techs ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for WUCT aggregates regulatory documents tied to ETRACS Whitney US Critical Technologies ETNs issued by UBS AG, a foreign private issuer. The core filings here are Forms 6-K, which provide interim financial and legal updates that are incorporated by reference into UBS AG’s Form F-3 registration statement for securities offerings.
In these Form 6-K reports, UBS AG discloses consolidated capitalization in US dollars under IFRS Accounting Standards, detailing short-term and long-term debt issued by UBS AG and its subsidiaries, funding from UBS Group AG, equity attributable to shareholders and non-controlling interests, and total capitalization. Such information helps investors understand the broader balance sheet context of the issuer behind the WUCT-linked ETNs.
The filings also explain how specific 6-K reports are incorporated into UBS AG’s Form F-3 registration statement and any outstanding prospectuses or offering circulars that reference those 6-Ks. This structure means that updates filed on Form 6-K become part of the official documentation for securities, including the ETRACS Whitney US Critical Technologies ETNs associated with WUCT.
Another Form 6-K on this page consists of the opinion of Homburger AG, acting as special Swiss counsel to UBS AG, which is filed as an exhibit to the Form F-3 registration statement and replaces a prior opinion. This highlights the role of legal opinions in UBS AG’s securities registration process.
On Stock Titan, users can access these filings in one place, with AI-powered tools available to summarize key sections, highlight important capitalization and legal disclosures, and help interpret how each new Form 6-K or related document fits into UBS AG’s overall reporting framework for the WUCT-linked ETNs.
UBS AG is offering $340,500 in Trigger Autocallable Contingent Yield Notes linked to the common stock of Palantir Technologies Inc. (PLTR) maturing 28 June 2027. The unsecured, unsubordinated notes pay a contingent coupon of 23.30% p.a., but only for months in which Palantir’s closing share price is at or above the coupon barrier of $85.94 (60% of the $143.23 initial level). Each monthly observation date also carries an automatic call: if Palantir closes at or above the initial level, investors receive par plus the applicable coupon and the note terminates early.
If not called before the final valuation date (24 June 2027), principal is protected only when the final share price is at or above the downside threshold of $85.94. Otherwise, repayment is reduced one-for-one with Palantir’s decline, potentially to zero. Investors therefore face both equity market risk and UBS credit risk. The notes settle T+2, are not exchange-listed, and carry limited liquidity. UBS’s internal models assign an estimated initial value of $9.81 versus the $10 issue price, while the underwriting discount is $0.125 per note.
- Trade date: 24 June 2025; settlement: 26 June 2025
- Minimum investment: 100 notes ($1,000)
- CUSIP: 90309J495; ISIN: US90309J4958
- Proceeds to UBS: $9.875 per note after fees
Key risks highlighted include potential loss of principal, the possibility of receiving few or no coupons, dependence on UBS’s solvency, and an illiquid secondary market.